Comparative in vitro Activity and Clinical Outcomes of Eravacycline, Tigecycline, and Omadacycline Against Carbapenem-Resistant Acinetobacter baumannii and Klebsiella pneumoniae [Corrigendum]
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Chen D, Lan H, Yang W, et al. Infect Drug Resist. 2026;19:1—13. https://doi.org/10.2147/IDR.S583973 There is an unintentional textual error in Figure 1 on page 4 of the published paper, the text “(n=4: CRAB, n=3; CRKP, n=1)” should read “(n=20: CRAB, n=15; CRKP, n=5)”. The authors apologize for the error and advise that it was purely a labelling oversight and does not alter the statistical analysis, results, or the scientific conclusions of the paper. The correct Figure 1 is shown below. Figure 1 Experimental Workflow.
Fields of Study & Subjects
Antibiotic Resistance in Bacteria
Antibiotics Pharmacokinetics and Efficacy
Antibiotic Use and Resistance
Publication details
- Journal / source
- Dove Medical Press (Taylor and Francis Group)
- Publication date
- 23 March 2026
- Language
- EN